These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25907159)

  • 1. Efficacy of idebenone in Duchenne muscular dystrophy.
    Mercuri E; Muntoni F
    Lancet; 2015 May; 385(9979):1704-1706. PubMed ID: 25907159
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial.
    Buyse GM; Voit T; Schara U; Straathof CSM; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; McDonald CM; Rummey C; Meier T;
    Lancet; 2015 May; 385(9979):1748-1757. PubMed ID: 25907158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy.
    Buyse GM; Voit T; Schara U; Straathof CS; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; Rummey C; Leinonen M; Mayer OH; Spagnolo P; Meier T; McDonald CM;
    Pediatr Pulmonol; 2017 Apr; 52(4):508-515. PubMed ID: 27571420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term data with idebenone on respiratory function outcomes in patients with Duchenne muscular dystrophy.
    Servais L; Straathof CSM; Schara U; Klein A; Leinonen M; Hasham S; Meier T; De Waele L; Gordish-Dressman H; McDonald CM; Mayer OH; Voit T; Mercuri E; Buyse GM;
    Neuromuscul Disord; 2020 Jan; 30(1):5-16. PubMed ID: 31813614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy.
    Buyse GM; Goemans N; van den Hauwe M; Meier T
    Pediatr Pulmonol; 2013 Sep; 48(9):912-20. PubMed ID: 23129412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy.
    Mayer OH; Leinonen M; Rummey C; Meier T; Buyse GM;
    J Neuromuscul Dis; 2017; 4(3):189-198. PubMed ID: 28869486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy.
    McDonald CM; Meier T; Voit T; Schara U; Straathof CS; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; Rummey C; Leinonen M; Spagnolo P; Buyse GM;
    Neuromuscul Disord; 2016 Aug; 26(8):473-80. PubMed ID: 27238057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial.
    Buyse GM; Goemans N; van den Hauwe M; Thijs D; de Groot IJ; Schara U; Ceulemans B; Meier T; Mertens L
    Neuromuscul Disord; 2011 Jun; 21(6):396-405. PubMed ID: 21435876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home-Based Monitoring of Pulmonary Function in Patients with Duchenne Muscular Dystroph.
    Buyse GM; Rummey C; Meier T; Leinonen M; Voit T; McDonald CM; Mayer OH
    J Neuromuscul Dis; 2018; 5(4):419-430. PubMed ID: 30282375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor.
    Scheuerbrandt G
    Acta Myol; 2015 May; 34(1):14. PubMed ID: 26155065
    [No Abstract]   [Full Text] [Related]  

  • 11. Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy.
    Kim S; Zhu Y; Romitti PA; Fox DJ; Sheehan DW; Valdez R; Matthews D; Barber BJ;
    Neuromuscul Disord; 2017 Aug; 27(8):730-737. PubMed ID: 28645460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Discovery of Therapies for Duchenne Muscular Dystrophy.
    Blat Y; Blat S
    J Biomol Screen; 2015 Dec; 20(10):1189-203. PubMed ID: 25975656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction. Idebenone in the treatment of Friedreich ataxia.
    Pandolfo M
    J Neurol; 2009 Mar; 256 Suppl 1():1-2. PubMed ID: 19283343
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of noben (idebenone) in the complex treatment of episodic and chronic migraine].
    Koreshkina MI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):98-101. PubMed ID: 20726168
    [No Abstract]   [Full Text] [Related]  

  • 15. [Idebenone (noben) -- from theory to practice].
    Rachin AP; Averchenkova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):81-4. PubMed ID: 21666596
    [No Abstract]   [Full Text] [Related]  

  • 16. Idebenone treatment in Leber's hereditary optic neuropathy.
    Carelli V; La Morgia C; Valentino ML; Rizzo G; Carbonelli M; De Negri AM; Sadun F; Carta A; Guerriero S; Simonelli F; Sadun AA; Aggarwal D; Liguori R; Avoni P; Baruzzi A; Zeviani M; Montagna P; Barboni P
    Brain; 2011 Sep; 134(Pt 9):e188. PubMed ID: 21810891
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
    Parkinson MH; Schulz JB; Giunti P
    J Neurochem; 2013 Aug; 126 Suppl 1():125-41. PubMed ID: 23859348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idebenone (Raxone°) and Leber hereditary optic neuropathy.
    Prescrire Int; 2017 Feb; 26(179):41. PubMed ID: 30726629
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual improvement with the use of idebenone in the treatment of Wolfram syndrome.
    Bababeygy SR; Wang MY; Khaderi KR; Sadun AA
    J Neuroophthalmol; 2012 Dec; 32(4):386-9. PubMed ID: 23196951
    [No Abstract]   [Full Text] [Related]  

  • 20. Idebenone for Leber's hereditary optic neuropathy.
    Gueven N
    Drugs Today (Barc); 2016 Mar; 52(3):173-81. PubMed ID: 27186591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.